search
  • all asset classes
    •  
  • global coverage
  • real-time reporting
    •  
  • "All the G-14 dealers who are our major counterparties are on the triResolve service.

     As we increase the frequency and scope of our reconciliation activities, we can accomplish our goals quickly in one place.

    Also, the speed of implementation makes transitioning to triResolve very easy."

    Marc Valdes  
    Head of Collateral Management & Funding   BlueMountain  

home > services > triResolve
triResolve - portfolio reconciliation & counterparty exposure management service
triResolve


Portfolio reconciliation and counterparty exposure management 

 




triResolve offers a range of capabilities that enhance control over all aspects of OTC derivatives counterparty exposure management and margin call management. triResolve’s initial innovation, proactive portfolio reconciliation, has become the industry standard. Now, TriOptima has expanded its triResolve service to address other operational and credit risk challenges in the margin call management process.

Proactive portfolio reconciliation for all OTC derivative trades
With over 7 million trades being reconciled regularly through triResolve, proactive reconciliation is now expected by management and regulators. A web-based community network with more than 1000 institutions using the service, triResolve performs over 57,000 group reconciliations (over 325,000 legal entity level reconciliations) per week. Key performance reports are generated by triResolve users for their weekly regulatory submissions. And, most importantly, the work flow process for break management is transparent and efficient both internally and with the counterparty.

Dispute prevention and resolution
triResolve highlights any areas of dispute from the individual transaction level up to the margin call. Users have access to a web-based, flexible platform that enables communications between counterparties and even internally to provide detailed information to resolve differences. In the proactive reconciliation process, differences are researched immediately and resolved so they don’t persist contributing to disputed collateral calls. However, if a collateral dispute does arise, the flexibility and sophistication of the triResolve communications capability enables counterparties to research and resolve the problems in real time.

Margin call management

Streamlining the margin call management process is now a priority for the OTC derivatives industry as the need to reduce operational and credit risk in bilateral relationships has accelerated. triResolve has applied its expertise to the range of challenges in the bilateral collateralization process introducing margin call calculation and administration functionality as well as reconciliation of key ISDA CSA terms. Margin calls can be issued, accepted or disputed on triResolve which complies with the ISDA standard for electronic margin calls.

Real time management information reporting
A critical feature of triResolve is the advanced analytics and reporting functionality it offers users. They can drill down to any level of the data to identify root causes of problems in multiple dimensions (e.g., counterparty, asset class, etc.) and produce reports targeted to the needs of all management levels from the most senior credit officer to the head of collateral management – all of this in real time.




Related articles
Insight providers: Mary Harris, Business Manager triResolve and Susan Hinko, Head of Industry Relations, TriOptima The new year brings with it an onslaught of requirements for managing OTC derivative portfolios, cleared an

Insight provider: David White, triResolve Product Marketing Executive, TriOptima In a Q&A, TriOptima’s David White explores the impact new financial regulation will have on portfolio reconciliation and dis

[video] Insight provider: Raf Pritchard, CEO triResolve, TriOptima Raf Pritchard, CEO of triResolve, speaks to Tabb’s Kevin McPartland about how TriOptima is tailoring its services in response to changes within

Insight provider: Susan Hinko, Global Head of Industry Relations. The continuing ISDA-sponsored pilot of proactive portfolio reconciliation for OTC derivatives in the Asia Pacific region is further evidence of the globali

Please enter your full name.

Disclaimer
Interest Rate Trade Reporting Repository
Terms and Conditions for Access and Use


1. Scope of Agreement
    These terms and conditions (this "Agreement") govern your access to and use of any public repository reports of OTC interest rate derivatives (each a "Report") produced by TriOptima AB ("TriOptima"), as described on the information web page regarding the repository. You must accept this Agreement to access and use Reports. You accept the Agreement by clicking the "I Agree" button on the bottom of this page. TriOptima may at any time, without advance or specific notice, amend this Agreement. Hence, you are expected to review and accept this Agreement each time you wish to access any Report through this website.


2. Intellectual property rights, license to use
    You acknowledge that TriOptima is the sole and exclusive owner of any and all intellectual property rights to the structure and layout of any Report.


    TriOptima hereby grants to you a non-exclusive license to use Reports in accordance with this Agreement.


3. Prohibited use of Reports
    You must not use any Report or the information contained in any Report in a manner that may harm or be detrimental to TriOptima, including without limitation, to use any Report to directly or indirectly compete or promote competition with TriOptima.


    You are not allowed to use TriOptima's name or any trademarks, trade names or service marks contained in any Report or this website in advertising, publicity or otherwise; neither are you allowed to copy any marks, specific characteristics or attributes of any Report for any other purpose than for making a lawful and contractually permitted copy of a Report.


4. Non-reliance, no warranty, disclaimer
    Each Report is provided to you free of charge. However, TriOptima does not warrant or undertake to make any Reports available to you; hence you acknowledge that TriOptima, in its sole discretion, may or may not make Reports available to you via this website or otherwise.


    Each Report is intended for information purposes only. Any information in a Report may at any time be superseded or replaced by new or updated information. Furthermore, the information contained in a Report is based on the information submitted by third parties for the purpose of inclusion in such Report. The information contained in a Report is neither checked, nor verified by TriOptima. Consequently, you acknowledge that Reports are for information purposes only, that they may not be relied upon for any purpose whatsoever, and that they are dependent upon, as regards their accuracy and completeness, the data submitted to TriOptima by third parties.


    The parties acknowledge that TriOptima makes no representation or warranty with respect to any Report or this website or any data or materials retrieved, obtained, provided or transmitted, by or to you, using this website. Each Report and this website and all such data and materials are being provided to you "as is". TriOptima hereby disclaims any and all representations and warranties, whether express or implied, including without limitation, any representation or warranty as to merchantability or fitness for a particular purpose, any representations or warranties arising from course of dealing or course of performance, and any representations or warranties of accuracy, reliability or functionality.


    To the maximum extent permitted by law, TriOptima disclaims all liability arising out of or in connection with the use of any Report or this website.

    Without prejudice to the above, TriOptima shall not be liable to you, or anyone claiming under or through you, for loss of profit, or any indirect or consequential loss or damages under or in connection with this Agreement, the use of any Report or this website, including without limitation, damages for loss of capital, interest, revenue, data or use, or interruption of business, even if you had been advised of the possibility of such damages.


    Notwithstanding anything to the contrary in this Agreement, TriOptima does not exclude or limit its liability for wilful misconduct, fraud or death or personal injury arising from TriOptima's negligence.


    For purposes of this clause, references to TriOptima shall be deemed to include its affiliates and their respective partners, officers, employees, directors, agents, contractors, representatives, successors and assigns.


5. Viruses, malware
    To the best of TriOptima's knowledge, Reports published on this website, this website and the server on which it resides are free from viruses and other malware. However, TriOptima cannot warrant this to be the case, and it is your responsibility to take precautions to prevent your computer and/or network to be affected by viruses or other malware. Hence, TriOptima does not assume any liability for any damage or loss, whether direct or indirect, including loss of data, caused to you by viruses or other malware from Reports published on this website, this website or the server on which it resides, including when you download any Report.


6. Applicable law, disputes
    This Agreement and any non-contractual obligations arising in connection with it shall be governed by English law, without regard to its principles of conflicting laws. Each party submits to the exclusive jurisdiction of the English courts for all purposes relating to this Agreement (including the enforcement of any determinations).
I agree    I decline